Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TherapeuticsMD Inc Announces Trading of Common Stock On NYSE MKT Under Symbol TXMD


Monday, 22 Apr 2013 09:15am EDT 

TherapeuticsMD Inc announced that its common stock has been approved for listing on the NYSE MKT, the premier U.S. equities market for listing and trading of small growth companies. Trading is expected to commence on the NYSE MKT on April 23, 2013, under the ticker symbol “TXMD”. 

Company Quote

4.15
0.11 +2.72%
21 Oct 2014